PEPITES


Study NameStudy TitleStudy TypeSponsorSponsor Type
PEPITESA double-blind, placebo-controlled, randomized Phase III Pivotal Trial to assess the efficacy and safety of peanut epicutaneous immunotherapy with Viaskin® peanut in peanut-allergic childrenClinical TrialDBV Technologies S.A.Industry Sponsored